Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis

Journal of Immunological Methods

Volumn 379, Issue 1-2, 2012, Pages 53-60

  Bonroy, C ^a   Van Praet, J ^a   Smith, V ^a   Van Steendam, K ^b   Mimori, T ^c   Deschepper, E ^b   Deforce, D ^b   Devreese, K ^a   De Keyser, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti extractable nuclear antigen antibodies; Anti PM Scl antibodies; Anti RNA polymerase III antibodies; Diagnostic accuracy; Lineblot; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; DNA TOPOISOMERASE; FIBRILLARIN;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; BLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOASSAY; LINEBLOTTING; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CENTROMERE; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA TOPOISOMERASES, TYPE I; FEMALE; HUMANS; IMMUNOLOGIC TECHNIQUES; MALE; MIDDLE AGED; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC;

EID: 84859741857     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.03.001     Document Type: Article

References (49)

1. Albon S., Bunn C., Swana G., Karim Y. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis. J. Immunol. Methods 2011, 365:126.
2. Altman R.D. Classification of disease: osteoarthritis. Semin. Arthritis Rheum. 1991, 20:40.
3. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315.
4. Ceribelli A., Cavazzana I., Franceschini F., Airo P., Tincani A., Cattaneo R., Pauley B.A., Chan E.K., Satoh M. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. J. Rheumatol. 2010, 37:2071.
5. Chang M., Wang R.J., Yangco D.T., Sharp G.C., Komatireddy G.R., Hoffman R.W. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin. Immunol. Immunopathol. 1998, 89:71.
6. Cohen J.A. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 1960, 37.
7. De Rycke L., Peene I., Hoffman I.E., Kruithof E., Union A., Meheus L., Lebeer K., Wyns B., Vincent C., Mielants H., Boullart L., Serre G., Veys E.M., De Keyser F. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann. Rheum. Dis. 2004, 63:1587.
8. Fries J.F., Hunder G.G., Bloch D.A., Michel B.A., Arend W.P., Calabrese L.H., Fauci A.S., Leavitt R.Y., Lie J.T., Lightfoot R.W., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990, 33:1135.
9. Fritzler M.J., von Muhlen C.A., Toffoli S.M., Staub H.L., Laxer R.M. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases. J. Rheumatol. 1995, 22:521.
10. Fujii T., Mimori T., Akizuki M. Detection of autoantibodies to nucleolar transcription factor NOR 90/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays. Arthritis Rheum. 1996, 39:1313.
11. Fujita Y., Fujii T., Nakashima R., Tanaka M., Mimori T. Aseptic meningitis in mixed connective tissue disease: cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases. Mod. Rheumatol. 2008, 18:184.
12. Genth E., Mierau R., Genetzky P., von Muhlen C.A., Kaufmann S., von Wilmowsky H., Meurer M., Krieg T., Pollmann H.J., Hartl P.W. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum. 1990, 33:657.
13. Greiner M., Pfeiffer D., Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev. Vet. Med. 2000, 45:23.
14. Hanke K., Bruckner C.S., Dahnrich C., Huscher D., Komorowski L., Meyer W., Janssen A., Backhaus M., Becker M., Kill A., Egerer K., Burmester G.R., Hiepe F., Schlumberger W., Riemekasten G. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res. Ther. 2009, 11:R22.
15. Hanke K., Becker M.O., Brueckner C.S., Meyer W., Janssen A., Schlumberger W., Hiepe F., Burmester G.R., Riemekasten G. Anticentromere-a and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis. J. Rheumatol. 2010, 37:2548.
16. Harvey G.R., McHugh N.J. Serologic abnormalities in systemic sclerosis. Curr. Opin. Rheumatol. 1999, 11:495.
17. Ho K.T., Reveille J.D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res. Ther. 2003, 5:80.
18. Hoffman I.E., Peene I., Veys E.M., De Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin. Chem. 2002, 48:2171.
19. Jacobsen S., Halberg P., Ullman S., Van Venrooij W.J., Hoier-Madsen M., Wiik A., Petersen J. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br. J. Rheumatol. 1998, 37:39.
20. Jaskowski T.D., Wilson A., Hill H.R., Tebo A.E. Diagnostic assays for anti-PM/Scl IgG antibodies: heterogeneity in antibody response or lack of standardization?. Clin. Chim. Acta 2011, 412:1100.
21. Koenig M., Dieude M., Senecal J.L. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmun. Rev. 2008, 7:588.
22. Kuwana M., Kimura K., Hirakata M., Kawakami Y., Ikeda Y. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases. Ann. Rheum. Dis. 2002, 61:842.
23. Kuwana M., Okano Y., Pandey P.P., Silver R.M., Fertig N., Medsger T.A. Enzyme-linked immunosorbent assay for detection of RNA-polymerase III antibody. Arthritis Rheum. 2005, 52:2425.
24. LeRoy E.C., Medsger T.A. Criteria for the classification of early systemic sclerosis. J. Rheumatol. 2001, 28:1573.
25. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., Rowell N., Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 1988, 15:202.
26. Maes L., Blockmans D., Verschueren P., Westhovens R., De Beeck K.O., Vermeersch P., Van den Bergh K., Burlingame R.W., Mahler M., Bossuyt X. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma. Clin. Chim. Acta 2010, 411:965.
27. Mahler M., Fritzler M.J. The changing landscape of the clinical value of the PM/Scl autoantibody system. Arthritis Res. Ther. 2009, 11:106.
28. Mahler M., Raijmakers R. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun. Rev. 2007, 6:432.
29. Meheus L., van Venrooij W.J., Wiik A., Charles P.J., Tzioufas A.G., Meyer O., Steiner G., Gianola D., Bombardieri S., Union A., De Keyser S., Veys E., De Keyser F. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin. Exp. Rheumatol. 1999, 17:205.
30. Meyer O., De Chaisemartin L., Nicaise-Roland P., Cabane J., Tubach F., Dieude P., Hayem G., Palazzo E., Chollet-Martin S., Kahan A., Allanore Y. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. J. Rheumatol. 2010, 37:125.
31. Oddis C.V., Okano Y., Rudert W.A., Trucco M., Duquesnoy R.J., Medsger T.A. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum. 1992, 35:1211.
32. Okano Y., Steen V.D., Medsger T.A. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann. Intern. Med. 1993, 119:1005.
33. Phan T.G., Wong R.C., Adelstein S. Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin. Diagn. Lab. Immunol. 2002, 9:1.
34. Pottel H., Wiik A., Locht H., Gordon T., Roberts-Thomson P., Abraham D., Goossens K., Dobbels C., De Bosschere K., Hulstaert F., Meheus L. Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders. Clin. Exp. Rheumatol. 2004, 22:579.
35. Reimer G., Rose K.M., Scheer U., Tan E.M. Autoantibody to RNA polymerase I in scleroderma sera. J. Clin. Invest. 1987, 79:65.
36. Reimer G., Steen V.D., Penning C.A., Medsger T.A., Tan E.M. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988, 31:525.
37. Reveille J.D., Solomon D.H. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003, 49:399.
38. Russo K., Hoch S., Dima C., Varga J., Teodorescu M. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J. Rheumatol. 2000, 27:142.
39. Santiago M., Baron M., Hudson M., Burlingame R.W., Fritzler M.J. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J. Rheumatol. 2007, 34:1528.
40. Satoh T., Ishikawa O., Ihn H., Endo H., Kawaguchi Y., Sasaki T., Goto D., Takahashi K., Takahashi H., Misaki Y., Mimori T., Muro Y., Yazawa N., Sato S., Takehara K., Kuwana M. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. Rheumatology (Oxford) 2009, 48:1570.
41. Sharif R., Fritzler M.J., Mayes M.D., Gonzalez E.B., McNearney T.A., Draeger H., Baron M., Furst D.E., Khanna D.K., Del Junco D.J., Molitor J.A., Schiopu E., Phillips K., Seibold J.R., Silver R.M., Simms R.W., Perry M., Rojo C., Charles J., Zhou X., Agarwal S.K., Reveille J.D., Assassi S., Arnett F.C. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J. Rheumatol. 2011, 38:1622.
42. Steen V.D. Autoantibodies in systemic sclerosis. Semin. Arthritis Rheum. 2005, 35:35.
43. Tamby M.C., Bussone G., Mouthon L. Antitopoisomerase 1 antibodies in systemic sclerosis: how to improve the detection?. Ann. N. Y. Acad. Sci. 2007, 1109:221.
44. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271.
45. Van Eenennaam H., Vogelzangs J.H., Bisschops L., Te Boome L.C., Seelig H.P., Renz M., De Rooij D.J., Brouwer R., Pluk H., Pruijn G.J., Van Venrooij W.J., Van Den Hoogen F.H. Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations. Clin. Exp. Immunol. 2002, 130:532.
46. Van Praet J.T., Vander Cruyssen B., Bonroy C., Smith V., Delanghe J., De Keyser F. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies. Clin. Exp. Rheumatol. 2009, 27:971.
47. Van Praet J.T., Van Steendam K., Smith V., De Bruyne G., Mimori T., Bonroy C., Elewaut D., Deforce D., De Keyser F. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach. Rheumatology 2011, 50:1302.
48. Villalta D., Morozzi G., Tampoia M., Alpini C., Brusca I., Salgarolo V., Papisch W., Bizzaro N. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis. Clin. Chim. Acta 2010, 411:710.
49. Walker J.G., Fritzler M.J. Update on autoantibodies in systemic sclerosis. Curr. Opin. Rheumatol. 2007, 19:580.